Estados financieros detallados de Genelux Corporation (GNLX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -17.6%, margen operativo -4452.0%, margen neto -4224.1%.
Al precio actual de $2.34, GNLX presenta beneficios negativos (P/E no significativo) y un ROE del -195.42%. La capitalización bursátil es de $105M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | $11.1M | $170000 | $8000 | $8000 |
| Coste de Ventas | 0 | $658000 | $895000 | $968000 | $1.0M | $903000 | $574000 |
| Beneficio Bruto | 0 | -$658000 | -$895000 | $10.1M | -$848000 | -$895000 | -$566000 |
| I+D | $7.5M | $6.2M | $6.3M | $9.1M | $12.8M | $19.0M | $19.9M |
| Generales y Administrativos | $3.3M | $6.2M | $8.3M | $5.0M | $11.6M | $12.7M | $13.4M |
| Gastos Operativos | $10.9M | $11.8M | $13.7M | $13.1M | $23.3M | $30.8M | $32.6M |
| Beneficio Operativo | -$10.9M | -$12.4M | -$14.6M | -$3.0M | -$24.2M | -$31.7M | -$33.2M |
| EBITDA | -$10.5M | -$11.8M | -$13.7M | -$1.7M | -$26.5M | -$29.0M | -$31.6M |
| Gastos por Intereses | $761000 | $1.2M | $1.8M | $1.4M | $4.0M | 0 | 0 |
| Beneficio Antes de Impuestos | -$11.6M | -$13.6M | -$16.4M | -$4.1M | -$28.3M | -$29.9M | -$32.1M |
| Impuestos | 0 | 0 | 0 | $1.1M | 0 | 0 | 0 |
| Beneficio Neto | -$11.6M | -$14.9M | -$17.8M | -$5.2M | -$28.3M | -$29.9M | -$32.1M |
| BPA | $-0.49 | $-0.58 | $-0.69 | $-0.21 | $-1.16 | $-0.95 | $-0.86 |
| BPA Diluido | $-0.49 | $-0.58 | $-0.69 | $-0.21 | $-1.16 | $-0.95 | $-0.86 |
| Acciones en Circulación (Diluidas) | $23.6M | $23.6M | $23.6M | $24.6M | $24.4M | $31.5M | $37.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | $8000 | 0 | 0 |
| Beneficio Bruto | 0 | -$140000 | -$1000 | 0 |
| Beneficio Operativo | -$8.2M | -$9.4M | -$8.4M | -$9.6M |
| EBITDA | -$7.8M | -$9.8M | -$7.1M | -$9.5M |
| Beneficio Neto | -$8.0M | -$9.2M | -$7.1M | -$9.5M |
| BPA | $-0.21 | $-0.25 | $-0.22 | $-0.21 |
| BPA Diluido | $-0.21 | $-0.25 | $-0.22 | $-0.21 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $425000 | $11.3M | $4.5M | $397000 | $9.4M | $8.6M | $5.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $13.8M | $22.3M | $9.3M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $551000 | $11.5M | $5.8M | $1.9M | $24.2M | $31.5M | $15.1M |
| Inmovilizado Material | $2.6M | $2.5M | $2.2M | $2.0M | $3.6M | $3.1M | $3.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $3.3M | $14.0M | $8.1M | $5.5M | $27.9M | $34.7M | $19.0M |
| Cuentas por Pagar | 0 | $927000 | $4.5M | $6.8M | $3.8M | $5.6M | $4.4M |
| Deuda a Corto | $4.6M | $3.6M | $6.2M | $16.4M | 0 | $329000 | 0 |
| Pasivos Corrientes | $14.7M | $14.5M | $22.5M | $31.6M | $6.6M | $6.9M | $6.2M |
| Deuda a Largo | $13.0M | $21.7M | $18.0M | $8.5M | 0 | 0 | 0 |
| Pasivos Totales | $28.1M | $36.7M | $41.2M | $41.3M | $8.4M | $8.4M | $7.5M |
| Reservas | -$154.6M | -$168.2M | -$184.6M | -$189.8M | -$221.5M | -$251.4M | -$283.5M |
| Patrimonio Neto | -$24.8M | -$22.7M | -$33.1M | -$35.8M | $19.5M | $26.3M | $11.5M |
| Deuda Total | $18.0M | $26.1M | $25.3M | $26.4M | $2.5M | $1.9M | $1.7M |
| Deuda Neta | $17.5M | $14.7M | $20.8M | $26.0M | -$20.7M | -$29.0M | -$12.9M |
| Capital Circulante | -$14.2M | -$3.0M | -$16.7M | -$29.7M | $17.6M | $24.6M | $8.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $3.7M | $5.3M | $9.3M | $9.2M |
| Activos Totales | $25.0M | $19.0M | $32.4M | $26.2M |
| Pasivos Totales | $6.4M | $7.5M | $9.5M | $10.1M |
| Patrimonio Neto | $18.6M | $11.5M | $22.9M | $16.1M |
| Deuda Total | $1.6M | $1.7M | $2.5M | $2.4M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$11.6M | -$13.6M | -$16.4M | -$5.2M | -$28.3M | -$29.9M | -$32.1M |
| Amortizaciones | $477000 | $658000 | $895000 | $968000 | $1.0M | $903000 | $244000 |
| Compensación en Acciones | 0 | $5.3M | $4.3M | $2.4M | $5.2M | $6.1M | $5.9M |
| Cambio en Capital Circulante | $84000 | $381000 | $4.1M | -$1.7M | -$3.3M | $751000 | -$1.0M |
| Flujo de Caja Operativo | -$7.2M | -$7.2M | -$6.6M | -$3.6M | -$20.3M | -$21.2M | -$25.3M |
| Inversiones (CapEx) | -$1.8M | -$20000 | 0 | -$49000 | -$1.0M | -$381000 | -$1.1M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$9.0M | -$7.2M | -$6.6M | -$3.6M | -$21.3M | -$21.6M | -$26.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$6.6M | -$6.2M | -$6.1M | -$6.4M |
| Inversiones (CapEx) | -$517000 | -$436000 | -$921000 | -$1.5M |
| Flujo de Caja Libre | -$7.1M | -$6.6M | -$7.0M | -$8.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.3M | $810000 | $1.4M | $2.5M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | -98.5% | -95.3% | +0.0% |
| Crecimiento Beneficio Neto (anual) | | -27.8% | -19.7% | +70.7% | -443.4% | -5.6% | -7.6% |
| Crecimiento BPA (anual) | | -18.4% | -19.0% | +69.6% | -452.4% | +18.1% | +9.5% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +4.0% | -0.5% | +28.7% | +18.2% |
| Crecimiento FCF (anual) | | +19.7% | +8.9% | +45.0% | -488.4% | -1.5% | -22.0% |
| Margen Bruto | | | | 91.3% | -498.8% | -11187.5% | -7075.0% |
| Margen Operativo | | | | -27.2% | -14214.7% | -396200.0% | -415175.0% |
| Margen EBITDA | | | | -15.6% | -15562.9% | -362075.0% | -394637.5% |
| Margen Neto | | | | -47.0% | -16645.3% | -373362.5% | -401812.5% |
| Margen FCF | | | | -32.7% | -12529.4% | -270112.5% | -329575.0% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -26.8% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.38 | $-0.31 | $-0.28 | $-0.15 | $-0.87 | $-0.69 | $-0.71 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $23.6M | $23.6M | $23.6M | $24.6M | $24.4M | $31.5M | $37.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -195.42% |
| Rentabilidad sobre capital invertido | -192.18% |
| Rentabilidad sobre activos | -128.96% |
| Margen bruto | -1762.50% |
| Margen operativo | -445200.00% |
| Margen neto | -422412.50% |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 2.39 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -12.55 | -10.60 | -8.91 | -29.29 | -12.08 | -2.48 | -5.07 |
| P/VC | -5.85 | -6.41 | -4.39 | -4.22 | 17.58 | 2.82 | 14.04 |
| P/V | 0.00 | 0.00 | 0.00 | 13.64 | 2013.26 | 9277.96 | 20261.21 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 91.3% | -498.8% | -11187.5% | -7075.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | -27.2% | -14214.7% | -396200.0% | -415175.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | -47.0% | -16645.3% | -373362.5% | -401812.5% |